Following Women With Postmenopausal Osteoporosis Treated With Bone Medicines
Follows women with postmenopausal osteoporosis treated with bone-strengthening drugs over time.
Plain-language title generated from the registry record
Registry title: Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis
Key facts
- Where
- Clermont-Ferrand, FranceSee the site
Where in France
- CHU de Clermont-FerrandClermont-Ferrand, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Clermont-Ferrand
- Trial code
- NCT05228262
- Record updated
- 10 October 2022
- Original description
This study aims to follow a cohort of osteoporotic patients treated with anti-osteoporotic drugs and to evaluate the impact of these treatments on the osteoporosis-cardiovascular-sarcopenia triad and on pain.Read full original descriptionShow less
Study on Vascular Function, Sarcopenia and Pain in Treated Postmenopausal Osteoporosis
This study aims to follow a cohort of osteoporotic patients treated with anti-osteoporotic drugs and to evaluate the impact of these treatments on the osteoporosis-cardiovascular-sarcopenia triad and on pain.
Inclusion: Women aged 50 years or older with postmenopausal osteoporosis, whether fractured or not, requiring initiation of treatment with antiosteoporotic drugs (bisphosphonates, raloxifene, teriparatide, denosumab and others to come for this indication, including romosozumab), either orally or by injection, as part of their care and management; Able to give informed consent to participate in research; Affiliation to a Social Security system.
Exclusion: Patient with a medical and/or surgical history deemed by the investigator or his/her representative to be incompatible with the trial; Patient with chronic renal failure, defined as glomerular filtration rate < 30 mL.min-1 estimated by CKD-EPI; Patient under legal protection or deprived of liberty; Refusal to participate.